Many overlook the warnings preceding workout classes that encourage consulting a doctor before participating in rigorous exercise.
AbbVie inks deal for Medincell’s long-acting injectable platform worth up to $1.9B
AbbVie is betting more than $1.9 billion on a French biotech’s long-acting injectable technology. The deal gives Medincell $35 million upfront and up to $1.9